LBF20207PG38: Difference between revisions
No edit summary |
No edit summary |
||
(17 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
Line 4: | Line 6: | ||
|LipidBank=XPR1759 | |LipidBank=XPR1759 | ||
|LipidMaps=LMFA03010077 | |LipidMaps=LMFA03010077 | ||
|SysName= 9alpha,11alpha,15S- | |SysName=(9alpha,11alpha,15S) -Trihydroxy-prosta- (trans-5,trans-13) -dien-1-oic acid | ||
|Common Name=&&5-trans Prostaglandin | |Common Name=&&5-trans Prostaglandin F_2 alpha&&(9alpha,11alpha,15S) -Trihydroxy-prosta- (5E,13E) -dien-1-oic acid&& | ||
|Source= | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
|Biological Activity=5-trans Prostaglandin F2 alpha shows incease of respiratory rate in rabbit.[[Reference:Brookes_LG:Marshall_RC:,J. Pharm. Pharmacol.,1974,26 Suppl,80|{{RelationTable/GetFirstAuthor|Reference:Brookes_LG:Marshall_RC:,J. Pharm. Pharmacol.,1974,26 Suppl,80}}]] | |||
}} | }} | ||
{{Lipid/Footer}} |
Latest revision as of 08:34, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1759 |
LipidMaps | LMFA03010077 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG38 |
5-trans Prostaglandin F2α | |
---|---|
Structural Information | |
(9α,11α,15S) -Trihydroxy-prosta- (trans-5,trans-13) -dien-1-oic acid | |
| |
Formula | C20H34O5 |
Exact Mass | 354.240624198 |
Average Mass | 354.48096000000004 |
SMILES | C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)CC |
Physicochemical Information | |
5-trans Prostaglandin F2 alpha shows incease of respiratory rate in rabbit. Brookes_LG et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|